Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study

By Javier Fernández, J. Acevedo, M. Castro, O. García, C. Rodríguez de Lope, D. Roca, M. Pavesi, E. Solà, L. Moreira, Aníbal Silva and 5 more. Hepatology, 2012

605 citations recorded by the source corpus.

Subfields: Food Science, Hepatology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/066b6d3b62b3f7538aeecf76da6455eb2b3261c8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Food Science

1. J. Vila

In Hepatology

1. P. Ginés
2. M. Bernardi
3. P. Angeli
4. G. Garcia‐Tsao
5. W. Laleman
6. J. Trebicka
7. B. Runyon
8. Rajeshwar P. Mookerjee

In Infectious Diseases

1. J. Vila

Citations in the corpus

• Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases (2021, background): “Infections by MDRO represent 35% of overall infections in patients with cirrhosis (171, 172), which has led to a decreased response to the recommended initial empirical antibiotic (172).”
• Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. (2014, background): “Recent data from Spain clearly support the former contention [4].”
• Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012 (2013, background): “occurs in a patient who has received antibiotics in the recent past.(135,212)”
• EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. (2018, background): “All these factors are well kown risk factors for the development of infections sustained by MDROs [266].”